ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 13 filers reported holding ARCA BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,971,000 | +17.4% | 1,460,209 | 0.0% | 0.08% | +39.0% |
| Q3 2017 | $1,679,000 | -52.1% | 1,460,209 | 0.0% | 0.06% | -53.9% |
| Q2 2017 | $3,505,000 | -5.9% | 1,460,209 | 0.0% | 0.13% | -1.5% |
| Q1 2017 | $3,724,000 | -10.5% | 1,460,209 | 0.0% | 0.13% | -21.2% |
| Q4 2016 | $4,162,000 | +0.7% | 1,460,209 | 0.0% | 0.16% | -10.8% |
| Q3 2016 | $4,132,000 | -2.4% | 1,460,209 | 0.0% | 0.18% | -15.9% |
| Q2 2016 | $4,235,000 | -16.4% | 1,460,209 | 0.0% | 0.22% | -34.5% |
| Q1 2016 | $5,067,000 | -25.4% | 1,460,209 | 0.0% | 0.34% | -22.2% |
| Q4 2015 | $6,790,000 | -6.3% | 1,460,209 | 0.0% | 0.43% | -9.4% |
| Q3 2015 | $7,243,000 | – | 1,460,209 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 1,460,209 | $3,505,000 | 0.13% |
| Aveo Capital Partners, LLC | 93,667 | $225,000 | 0.08% |
| Tekla Capital Management LLC | 811,227 | $1,988,000 | 0.07% |
| ROYCE & ASSOCIATES LP | 179,847 | $441,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,216,840 | $2,981,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 576 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 11,018 | $26,000 | 0.00% |
| DEUTSCHE BANK AG\ | 60,308 | $144,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 16,181 | $39,000 | 0.00% |
| MORGAN STANLEY | 243 | $1,000 | 0.00% |